Mineralys Therapeutics (MLYS) Long-Term Investments (2023)

Mineralys Therapeutics has reported Long-Term Investments for 1 years, with the latest figure at $2.5 million in Q4 2023.

• Quarterly Long-Term Investments changed N/A year-over-year to $2.5 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $2.5 million (changed N/A YoY) and the FY2023 annual result came in at $2.5 million, changed N/A from the prior year.
• Long-Term Investments declined to $2.5 million in Q4 2023 per MLYS's latest filing, from $12.1 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $31.1 million in Q1 2023 and troughed at $2.5 million in Q4 2023.